Completed PHASE1 INTERVENTIONAL 1-arm NCT03691584

Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers (BAL)

A Phase 1, Open-label, Randomized, PK and Safety Study To Assess Bronchopulmonary Disposition of Intravenous TP-6076 in Healthy Men and Women

Sponsor: PRA Health Sciences

Conditions Healthy Subjects

Interventions Bronchoalveolar lavage TP-6076

Updated 9 times since 2018 Last updated: Dec 16, 2021 Started: Nov 26, 2018 Primary completion: Jun 30, 2019 Completion: Dec 18, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy Subjects and is currently completed. PRA Health Sciences leads this study, which shows 9 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2022 — Jul 2024 [monthly]

Completed PHASE1

Status: Unknown Status → Completed
Oct 2021 — Jan 2022 [monthly]

Unknown Status PHASE1

Status: Active Not Recruiting → Unknown Status

▶ Show 4 earlier versions

Jan 2021 — Oct 2021 [monthly]

Active Not Recruiting PHASE1
Oct 2019 — Jan 2021 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting
Jan 2019 — Oct 2019 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Nov 2018 — Jan 2019 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PRA Health Sciences
Tetraphase Pharmaceuticals, Inc

Data source: La Jolla Pharmaceutical Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom